Skip to content

NTHI NTHI Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.4×+0.1×
Pfizer logo
PfizerPFE
1.2×0.0×
Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Nuvectis Pharma, Inc. logo
Nuvectis Pharma, Inc.NVCT
2.3×-1.0×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
16.3×+4.3×
Nuvation Bio logo
Nuvation BioNUVB
7.4×-1.6×

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Debt / equity-0.1×

Where this comes from

Calculated from NTHI’s reported figures.

Based on the most recent quarter.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NTHI's current ratio?
NTHI (NTHI) reported current ratio of 0.1× in Q1 2026.
How has NTHI's current ratio changed year-over-year?
NTHI's current ratio decreased by 68.4% year-over-year, from 0.4× to 0.1×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.